Table 7.
Clinical details of subjects.
| Group 1 (RWH) | Group 2 (IVF) | |
|---|---|---|
| Number of samples | 165 | 64 |
| Age (years ± SEM) | 31.21 ± 0.53 | 36.56 ± 0.51 |
| Endometriosis | ||
| Diagnosis methods | Surgically confirmed | Self-report |
| Diagnosis | ||
| Yes | 67.9% (112/165) | 32.8% (21/64) |
| No | 29.1% (48/165) | 64.1% (41/64) |
| Unknown | 3.0% (5/165) | 3.1% (2/64) |
| Uterine fibroids | ||
| Diagnosis | ||
| Yes | 6.1% (10/165) | |
| No | 30.9% (51/165) | |
| Unknown | 63.0% (104/165) | 100% (64/64) |
| Adenomyosis | ||
| Diagnosis | ||
| Yes | 9.7% (16/165) | |
| No | 26.1% (43/165) | |
| Unknown | 64.2% (106/165) | 100% (64/64) |
| Histological cycle staging | ||
| Menstrual (M) | 6.7% (11/165) | 0% (0/64) |
| Early proliferative (EP) | 3.0% (5/165) | 0% (0/64) |
| Mid proliferative (MP) | 39.4% (65/165) | 6.3% (4/64) |
| Late proliferative (LP) | 9.7% (16/165) | 6.3% (4/64) |
| Early secretory (ES) | 9.7% (16/165) | 53.0% (34/64) |
| Mid secretory (MS) | 17.6% (29/165) | 34.4% (22/64) |
| Late secretory (LS) | 13.9% (23/165) | 0% (0/64) |